Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia

NCT00005896 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT00005896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia
Lead sponsor
University of Minnesota
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2000
Completion date
Not reported
Enrollment
6
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fanconi's anemia